SEC Form 4 · accession 0001055726-16-000057
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B. Weiner
Director
Period of report
May 13, 2016
Accepted (ET)
Jun 6, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 723,622 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | May 13, 2016 | A | 10,000 | A | — | — | Common Stock | 10,000 | 10,000 | D |
| Common Stock OptionF2 | $9.33 | May 13, 2016 | A | 10,000 | A | May 13, 2017 | May 13, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2017.
- F2Options to vest 100% on May 13, 2017.